EluraⓇ (capromorelin oral solution) 

Elura® (capromorelin oral solution)

Chronic kidney disease (CKD) leads to ongoing, progressive weight loss, which is associated with shorter survival.¹ Elura is the only FDA-approved treatment for the management of weight loss in cats with CKD. 

Why Choose Elura?

  • Pink 8/10 on yellow background
    More than 8 out of 10 cats maintained or gained weight.*²

  • Pink ghrelin molecules on yellow background
    Mimics the naturally occurring hormone ghrelin.

  • Pink syringe on yellow background
    Offers an oral solution with a low dosing volume developed just for cats.

  •  Pink calendar showing monthly view
    Approved for long-term use and safe to use daily.

Elura Dosing and Administration

Administer Elura orally at a dose of 2 mg/kg (0.9 mg/lb) or 0.1ml /kg (0.045 ml /lb) body weight once daily.

How Elura Works

Elura Mechanism of Action

Learn how Elura mimics the hormone ghrelin.

Elura helps cats with CKD gain weight.

Prescribe Elura at the first sign of weight loss to help your feline CKD patients gain weight and stay their fabulous selves.

Elura® (capromorelin oral solution) Resources

Elura Mechanism of Action

INDICATION: Elura® is indicated for management of weight loss in cats with chronic kidney disease.

IMPORTANT SAFETY INFORMATION: For oral use in cats only. Do not use in cats that have a hypersensitivity to capromorelin or in cats with hypersomatotropism (acromegaly). Elura® may increase serum glucose for several hours after dosing; use in cats with current or historical diabetes mellitus has not been evaluated and may not be appropriate. Use with caution in cats that may have cardiac disease, severe dehydration or hepatic dysfunction. Elura® has not been evaluated in cats younger than 5 months of age or in breeding, pregnant or lactating cats. The most common adverse reactions included vomiting, hypersalivation, inappetence, behavior change and lethargy. Please see Elura® product label for full prescribing information.